awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42281309-31FF084D-DB83-4792-871A-3E7EC3A14A92
Q42281309-31FF084D-DB83-4792-871A-3E7EC3A14A92
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42281309-31FF084D-DB83-4792-871A-3E7EC3A14A92
Fenofibrate reduces C-reactive protein levels in hypertriglyceridemic patients with high risks for cardiovascular diseases.
P2860
Q42281309-31FF084D-DB83-4792-871A-3E7EC3A14A92
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42281309-31FF084D-DB83-4792-871A-3E7EC3A14A92
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0995aa47bb75ba7d3df257dd188d43706d634beb
P2860
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.